
    
      This is a multi center, randomized, double blind study to evaluate the efficacy and safety of
      H1-Coil deep brain rTMS in subjects with bipolar depression, taking mood stabilizers and
      previously unsuccessfully treated with antidepressant medications. The study is designed for
      a period of 8 weeks of which up to 3 weeks subjects will be tapered down from their
      medications and treated for 5 weeks. Two follow up visits will be performed at week 6 and 8
      after the last TMS treatment. Mood and mental status will be closely monitored with standard
      psychological scales and assessments
    
  